Chinese herbal therapy and Western drug use, belief and adherence for hypertension management in the rural areas of Heilongjiang province, China

PLoS One. 2015 Apr 29;10(4):e0123508. doi: 10.1371/journal.pone.0123508. eCollection 2015.

Abstract

Background: Traditional Chinese medicine (TCM) including Chinese herbal therapy has been widely practiced in China. However, little is known about Chinese herbal therapy use for hypertension management, which is one of the most prevalent chronic conditions in China. Thus we described Chinese herbal therapy and western drug users, beliefs, hypertension knowledge, and Chinese herbal and western drug adherence and determinants of Chinese herbal therapy use among patients with hypertension in rural areas of Heilongjiang Province, China.

Methodology and principal findings: This face-to-face cross sectional survey included 665 hypertensive respondents aged 30 years or older in rural areas of Heilongjiang Province, China. Of 665 respondents, 39.7% were male, 27.4% were aged 65 years or older. At the survey, 14.0% reported using Chinese herbal therapy and 71.3% reported using western drug for hypertension management. A majority of patients had low level of treatment adherence (80.6% for the Chinese herbal therapy users and 81.2% for the western drug users). When respondents felt that their blood pressure was under control, 72.0% of the Chinese herbal therapy users and 69.2% of the western drug users sometimes stopped taking their medicine. Hypertensive patients with high education level or better quality of life are more likely use Chinese herbal therapy.

Conclusions and significance: Majority of patients diagnosed with hypertension use western drugs to control blood pressure. Chinese herbal therapy use was associated with education level and quality of life.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • China / epidemiology
  • Cross-Sectional Studies
  • Culture
  • Drugs, Chinese Herbal / therapeutic use*
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Medicine, Chinese Traditional* / methods
  • Middle Aged
  • Patient Compliance
  • Quality of Life

Substances

  • Antihypertensive Agents
  • Drugs, Chinese Herbal

Grants and funding

This study was funded by China Medical Board grant (Grant No. 08-929), the key program National Natural Science Foundation of China (Grant No. 71333003), Fund of Heilongjiang Province Education Department (Grant No. 12511316) and Heilongjiang Postdoctoral fund (Grant No. LBH-Z14175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.